13
Apr 2026
Beckman Coulter Diagnostics earns CE mark for new assay delivering bacterial vs viral infection results in approximately 20 minutes
Beckman Coulter Diagnostics, a Danaher company and global leader in clinical diagnostics, today announced it has received CE 2797 mark under IVDR for the Access MeMed BV assay, enabling broad availability of a high-throughput host‑response test that helps clinicians differentiate between bacterial and viral infections in approximately 20 minutes.